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ABSTRACT
Objectives: Infectious diarrhea, a leading cause of morbidity and deaths, is
less prevalent in breastfed infants compared with infants fed infant formula.
The dominant human milk oligosaccharide (HMO), a-1,2-fucosyllactose
(20-FL), has structural homology to bacterial adhesion sites in the intestine
and may in part explain the protective effects of human milk. We hypoth-
esized that 20-FL prevents diarrhea via competitive inhibition of pathogen
adhesion in a pig model for sensitive newborn infants.
Methods: Intestinal cell studies were coupled with studies on cesarean-
delivered newborn pigs (n¼ 24) without (control) or with inoculation of
enterotoxigenic Escherichia coli F18 (7.5 1010/day for 8 days) fed either
no (F18) or 10 g/L 20-FL (2FL-F18).
Results: In vitro studies revealed decreased pathogen adhesion to intestinal
epithelial cells with 20-FL (5 g/L; P< 0.001). F18 pigs showed more
diarrhea than control pigs (P< 0.01). Administration of 20-FL to F18
pigs failed to prevent diarrhea, although the relative weight loss tended
to be reduced (19 vs 124 g/kg, P¼ 0.12), higher villi were observed in
the distal small intestine (P< 0.05), and a trend toward increased proportion
of mucosa and activities of some brush border enzymes in the proximal
small intestine. In situ abundance of a-1,2-fucose and E coli was
similar between groups, whereas sequencing showed higher abundance of
Enterobacteriaceae in F18, Enterococcus in control and Lachnospiraceae
in 2FL-F18 pigs.
Conclusions: 20-FL inhibited in vitro adhesion of E coli F18 to epithelial
cells, but had limited effects on diarrhea and mucosal health in newborn pigs
challenged with E coli F18.
Key Words: a-1,2-fucosyllactose, E coli, human milk oligosaccharide,
infection, newborn pigs
(JPGN 2017;64: 310–318)
C ompared with formula feeding, breastfeeding reduces therisk of infectious diarrhea, a worldwide problem and a
leading cause of infant deaths, especially in the third world (1).
Both nutritional and bioactive components in human milk may be
responsible for this protective effect, and the human milk oligo-
saccharides (HMOs) have been suggested to play a role. They pass
largely undigested through the infant intestine (2), but are the third
most abundant nutrient group in human milk (3,4), whereas they are
present in only trace amounts in cow’s milk (5). One proposed
mechanism of HMOs is its decoy effect whereby HMOs competi-
tively prevent bacterial adhesion to the intestinal epithelium due to
What Is Known
 Breastfeeding reduces the risk of infectious diarrhea.
 Human milk oligosaccharides prevent bacteria-
induced diarrhea in older infants but limited infor-
mation is available from newborns.
 Piglets are sensitive to enteric infections, making
them good models to investigate dietary effects on
the gut in sensitive newborn infants.
What Is New
 a-1,2-Fucosyllactose reduced Escherichia coli F18
epithelial adhesion, but failed to prevent diarrhea
in newborn F18-challenged pigs. Marginal improve-
ments were seen for intestinal structure and function.
 a-1,2-Fucosyllactose supplementation has limited
protective effects on the newly colonized, immuno-
compromised newborn intestine. Benefits of human
milk oligosaccharide may be highly age, diet, and
dose dependent.
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structural homology to mucosal glycoconjugates that represent
bacterial adhesion sites (6). In line with this, antimicrobial effects
of HMOs have been demonstrated in several in vitro studies (7–9).
The most abundant HMO in human milk is a-1,2-fucosyl-
lactose (20-FL) (5). Cell and animal studies have shown that 20-FL is
structurally homologous to fucosylated intestinal adhesions sites
(H-2 antigens) for different bacteria, including pathogenic bacteria
such as Campylobacter jejuni and enterotoxigenic Escherichia coli
(ETEC) strains (9,10). The decoy effect of 20-FL has been demon-
strated in mice and human intestinal biopsies, in which a dose of
10 g/L competitively inhibited adhesion of C jejuni (9). Adminis-
tration of HMOs has also been shown to reduce intestinal lesions in
a newborn rat model of necrotizing enterocolitis (11), and infants
receiving mother’s milk with high concentrations of 20-FL had
fewer cases of diarrhea caused by Campylobacter, E coli toxins or
caliciviruses (12). Fewer episodes of both respiratory and enteric
infections were also observed among infants who had a high intake
of HMOs (13).
In pig production, ETEC strains such as E coli F18 are a
major problem causing diarrhea in weanling pigs. The virulence
of E coli F18 depends on bacterial fimbriae binding to the
intestinal F18 receptor, H-2, a blood group antigen that carries a
a-1,2-fucosylated group (10). E coli F18 virulence further depends
on the host expression of FUT-1, the gene responsible for fucosyla-
tion of the H-2 antigen (14–16). Previously, FUT-1 expression, and
thereby the sensitivity toward E coli F18 infection, was not thought
to occur in pigs before 3 weeks of age (16,17). We, however,
recently documented similar expression levels of FUT-1 in preterm
and term newborn pigs and in weanling pigs, and we demonstrated
that E coli F18 induced diarrhea in newborn pigs deprived of sow’s
milk (18). Based on this, we hypothesized that dietary 20-FL inhibits
E coli F18 adhesion to intestinal epithelial cells and prevents F18
infectious diarrhea in newborn cesarean-delivered pigs. Immaturity
of the intestine and immune system makes this animal model very
sensitive to maldigestion and enteric pathogens and hence also to
the diet factors that may reduce pathogen influence and increase
mucosal immunity.
Antiadhesive effects of 20-FL in vitro was tested by incu-
bation of porcine jejunal epithelial PSIc1 cells, with E coli F18. The
20-FL tolerance and optimal doses of E coli F18 inoculation were
tested in 2 studies with newborn pigs, followed by an intervention
study with daily inoculations of 7.5 1010 E coli F18 and admin-
istration of 10 g/L 20-FL mixed into a cow’s milk–based
infant formula. Prevalence of diarrhea was the primary endpoint.
Secondary endpoints were body weight gain, blood gas values,
intestinal weight and proportions, mucosal enzyme activity, and
permeability. Finally we quantified in situ abundance of E coli and
the local endogenous intestinal production of a-1,2-fucose.
MATERIALS AND METHODS
In Vitro Cell Adhesion
Culture of E coli F18 and E coli ATCC 25922
The challenge strain (9910297–2STM, O138:F1814) and an
F18-negative control strain (American Type Culture Collection,
E coli ATCC 25922) were first grown overnight at 378C on blood
agar plates. A loop full (10 mL) of colony material was then
suspended in 4 mL sterile phosphate-buffered saline (PBS) and
poured onto an isosensitest agar (Oxoid, Roskilde, Denmark)
supplemented with Alizarin yellow 0.06% w/v (Merck) chosen
for optimal expression of F18 fimbria (19). Excess suspension
was discarded before overnight incubation at 378C and 10%
CO2. E coli was harvested from the plates in PBS and diluted in
antibiotics-free Advanced Dulbecco’s modified Eagle’s medium
(DMEM) for further analyses to OD600 0.5 (Pharmacia Biotech
GeneQuant pro, Cambridge, UK) corresponding to 3 108 cfu/mL.
Inhibition of E coli F18 Adhesion to PSIc1 Cells
PSIc1 cells (Bionutritech, Lunel, France) originating from
jejunal epithelium of an adult pig were cultured in DMEM supple-
mented with 2% fetal bovine serum (FBS), 2 mmol/L GlutaMAX,
40 U/mL penicillin, and 40 mg/mL streptomycin (all from Gibco,
Life Technologies, Carlsbad, CA) at 378C and 5% CO2 in a
humidified atmosphere. At 90% to 95% confluence, cells were
harvested by trypsinization using 10 Trypsin:EDTA (Gibco, Life
Technologies) and cultured in T75 culture flasks and 12-well plates
(TPP, Trasadingen, Switzerland) for genotyping and adhesion assay,
respectively. TaqMan single nucleotide polymorphism genotyping
was performed as previously described (18) to investigate guanine
(G)/adenine (A) polymorphism at nucleotide 307 of the FUT-1
gene, in which M307G/G or M307G/A represents susceptibility to
E coli F18 adhesion (15).
First, it was tested if E coli F18 and the control E coli ATCC
25922 strain adhered to PSIc1 cells. After cultivation in 12-well
plates, each well of confluent PSIc1 cells was added 500 mL E coli
solutions of OD600 0.5 to OD600 0.0005, giving a cell:bacteria ratio
of 1:1000 to 1:1. Cells and E coliwere then coincubated at 378C and
5% CO2 in a humidified atmosphere in medium without antibiotics.
After 2 to 3 hours, each well was washed twice in cold PBS, and
cells were harvested in 1 mL PBS, vortexed thoroughly and plated
in 10 dilutions on LB agar plates for bacterial enumeration.
To visualize adhesion of E coli F18, 3 hours coincubation and
subsequent washing in PBS was performed as above on 8 well
CultureSlides (BD Falcon, VWR, Herlev, Denmark) in a cell:bac-
teria ratio of 1:100. Bacteria were stained with LIVE/DEAD
BacLight stain (Molecular Probes, Life Technologies) according
to the manufacturer’s protocol and visualized using a florescence
microscope (Carl Zeiss, Oberkochen, Germany).
To test the antiadhesive effects of 20-FL, the PSIc1 cells and E
coli F18 or E coli ATCC 25922 (both at OD600 0.5) were incubated
as above, but before incubation themediumwas supplied with 20-FL
(produced utilizing technology from Glycosyn LLC, Medford, MA,
by DuPont Nutrition and Biosciences ApS, Copenhagen, Denmark)
in concentrations of 1 or 5 g/L compared with a control only added
saline. Lactose and maltose were used as control sugars at equiv-
alent molar concentrations. Bacteria were enumerated on agar
plates as above. The level of inhibition was calculated based on
8 to 14 replicates for E coli F18 and 4 replicates for E coli
ATCC 25922.
Pig Studies
All animal procedures were approved by the Danish National
Committee on Animal Experimentation.
Experiment 1: 20-FL Tolerance Study
A blinded study was set up to test pig tolerability toward 20-
FL to verify that large doses of 20-FL would not induce osmotic
diarrhea. Two sows (Danish LandraceLarge WhiteDuroc)
were selected for homozygosity (M307G/G) of the FUT-1 gene to
ensure at minimum heterozygosity of the offspring (18). Thirty pigs
were delivered at term by cesarean section and transferred to
individual temperature controlled incubators and, still under
anesthesia, fitted with a vascular catheter in the umbilical aorta
and an orogastric catheter. During the first 24 hours, pigs were
infused with plasma from the sow (4–7 mL/kg) to ensure passive
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immunization and with parenteral nutrition (7 mL/kg/h of Kabiven
and Vamin, Fresenius Kabi, Bad Homburg, Germany) adjusted to
the nutrient requirements of pigs. The above procedures has been
thoroughly described previously (20). To standardize the initial gut
colonization within each litter, each pig received an oral fecal
suspension from the sow on day 1 (1 mL with totally 2 106
cfu). A baseline blood sample was taken from the umbilical catheter
and analyzed for blood gasses on a GEM#Premier3000 (Instru-
mentation Laboratory, Zaventem, Bruxelles, Belgium). From day 2,
full enteral feeding was given as boluses of 15 mL/kg every 2 hours
with the exception of a 4 hours break during night, reaching a daily
dose of 150 mL/kg/day. Pigs were fed a milk replacer (MILEX, Arla
Foods, Viby, Denmark) with added protein (50 g/L Lacprodan DI-
9224, Arla Foods) as previously described (18). Based on birth
weight and sex, the pigs were allocated into 4 diet groups, supple-
menting the milk replacer with 20-FL to a total concentration of
10 g/L (FL-10, n¼ 7), 5 g/L (FL-5, n¼ 8), 2 g/L (FL-2, n¼ 7), or no
20-FL (controls, n¼ 8).
Body weight and temperature was recorded every morning
before feeding, and the consistency and amount of feces was scored
morning and evening, where 0 was absence of feces, 1 was normal
feces, 2 was pasty feces, 3 was droplets of watery feces, 4 was
moderate amounts of watery feces, and 5 was extensive amounts of
watery feces. Also, the level of hydration, as assessed by skinfold
test and piglet physical activity, was assessed twice daily. In case of
severe dehydration and apathy, the pigs were euthanized before the
scheduled euthanasia and tissue collection on day 5. Intestinal
permeability was determined as the post-mortem urine ratio
of lactulose and mannitol after oral administration of the 2 sugars
(0.5 and 0.3 g/kg, respectively) 3 hours before euthanasia (21). At
euthanasia, blood gasses were measured as above, and 10 cm
sections of proximal and distal small intestine were sampled for
determination of the wet and dry proportion of mucosa (21).
Experiment 2: E coli F18 Dose-Response Study
The optimal E coli F18 inoculation dose was then identified
in a dose-response study. Thirty-one term pigs were delivered by
caesarean section from 2 sows, fitted with orogastric and umbilical
catheters, immunized with sow’s serum, and nourished by parent-
eral nutrition as described for experiment 1. For the following
4 days, the pigs were fed 15 mL/kg/3 hours (Milex formula as above
supplemented with 23 g/L Lacprodan, DI9224) until euthanasia on
day 5. The pigs were randomly assigned to 4 different treatment
groups, controls (CON, n¼ 8) or 3 doses of F18, low dose (LOW,
1 107 CFU/day, n¼ 9), medium dose (MED, 2 108 CFU/day,
n¼ 7), and high dose (HIGH, 8 109 CFU/day, n¼ 7). E coli F18
was cultured overnight as described above, and harvested with
10 mL PBS. From the first day and throughout the experiment all
LOW, MED, and HIGH pigs were inoculated daily with 1 mL F18
suspension. The suspension was given through the orogastric
catheter followed 5 mL of the Milex formula. Initial gut coloniza-
tion was standardized by giving 1 mL of maternal fecal suspension,
as described in experiment 1. Body weight was recorded daily and
fecal consistency and amount was scored twice daily as described
for experiment 1. Likewise, clinical condition, hydration, intestinal
permeability, and mucosal proportions were measured. Sections of
distal small intestine were formalin fixed and paraffin embedded for
fluorescence in situ hybridization (FISH) with an E coli–specific 16
s rRNA probe (S-S-E coli-1161, 50 GCATAAGCGTCGCTGCCG
3023) labeled with isothiocyanate derivative (CY3, red signal) to
evaluate abundance of E coli in the proximal and distal small
intestine. In short, 3 mm tissue sections were mounted on glass
slides (Superfrost/Plus slides, Menzel-Gla¨ser, Braunschweig,
Germany), deparaffinated in xylene, dehydrated in ethanol, hybri-
dized overnight with the probe at 498C using Shandon Coverplates
and Sequenza immunostaining workstations (Thermo Scientific,
Waltham, MA) followed by 3 washing in hybridization buffer
(Tris 0.1 mol/L, NaCl 0.9 mol/L, 0.1% SDS, pH 7.2) and
3 washing in washing buffer (Tris 0.1 mol/L, NaCl 0.9 mol/L,
pH 7.2). An Axioimager M1 epifluorescence microscope (Carl
Zeiss) was used for visualization and images were obtained using
an AxioCamMRm version 3 monochrome camera and multidimen-
sional acquisition in the software AxioVision version 4.5
(Carl Zeiss). Based on the abundance of E coli, each pig was given
a standardized score where 1¼ no bacteria, 2¼ few bacteria,
3¼ some bacteria, and 4¼many bacteria in the tissue section.
Experiment 3: 20-FL F18 Infection Study
Finally, an intervention study was performed to test whether
20-FL inhibited E coli F18 infectious diarrhea. Twenty-five pigs
were delivered at term by cesarean section from 2 FUT-1 homo-
zygous sows (Danish LandraceLarge WhiteDuroc). As
described above, the pigs were prepared with umbilical and oro-
gastric tubes, infused with parenteral nutrition and sow’s plasma,
inoculated with maternal feces, and from day 2 transferred to full
enteral feeding with boluses of milk replacer. Based on birth weight
and sex, the pigs were allocated into 3 groups. One group was
inoculated daily with 7.5 1010 E coli F18 (F18, n¼ 9), 1 group
was given the same dose of E coli F18 plus 10 g/L 20-FL in the milk
replacer as described in the tolerance study above (2FL-F18, n¼ 8)
and 1 control group received only milk replacer (control, n¼ 8). E
coli F18 was cultured overnight at 10% CO2 on Iso-sensitest agar
with Alizarin yellow as described above, and harvested with 10 mL
PBS, of which each pig received 1 mL. On day 1, E coli F18 was
given 1 mL of the respective diets, while inoculations the following
days were followed by enteral feeding. The sensitivity toward diets
and pathogen inoculation were followed until euthanasia on day 8,
unless severe dehydration and apathy required euthanasia
beforehand.
Body weight was recorded every second day and clinical
evaluation was assessed as above. Fecal consistency scores were
evaluated morning and evening using a scoring system, where
0¼ absence of feces, 1¼ normal feces, 2¼ pasty feces, and
3¼watery feces. Blood gasses at birth and at euthanasia, intestinal
permeability, and mucosal proportions were obtained as above.
Sections of proximal and distal small intestine were snap frozen for
activity determination of 6 brush border enzymes (22).
Sections of distal small intestine were formalin fixed and
paraffin embedded for villus height measurements (using the
ImageJ software, version 1.22 c US National Institutes of Health,
Bethesda, MD) and evaluation of mucosal damage and villus
atrophy or degradation. The same tissues were evaluated for in
situ E coli abundance evaluated by FISH as described for exper-
iment 2. For microbiota analyses, total DNA of the colon content
was extracted and the microbiota composition determined using
tag-encoded 16S rRNA gene MiSeq-based high-throughput sequen-
cing (Illumina, San Diego, CA), as previously described (23). The
Quantitative Insight Into Microbial Ecology (QIIME, version 1.7.0)
and UPARSE methods were used to analyze the sequencing data.
To determine the level of 2-linked fucosylation in the distal
small intestine, the tissue sections were hybridized with a-1,2-
fucose–specific lectin, Ulex europaeus agglutinin I (24) labeled
with fluorescein isothiocyanate (green). In short, tissue sections
were deparaffinated and dehydrated as above, washed in 1 PBS
for 1 hour, permeabilized in 1 PBS with 1% TritonX for 1 hour,
hybridized with 0.5% lectin in 1 PBS and 2% BSA protected from
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light for 1 hour and finally washed in 1 PBS. All procedures were
performed at room temperature. Sections were evaluated under
microscope as above and given a score where 0¼ no staining,
1¼ few positive stained goblet cells, 2¼ several positive stained
goblet cells, mainly in the crypt area or moderate luminal staining,
3¼ abundant positive stained goblet cells along the entire mucosal
lining, and 4¼ abundant positive stained goblet cells along the
entire mucosal lining together with extensive luminal staining.
Statistical Analyses
Data analyses were performed in R version 3.0.1. Treatment
effects on diarrhea and weight development were analyzed using the
lmer function of repeated measurement analysis with litter and pig
as random variable and the factors treatment and time as fixed
variables. In vitro adhesion data and treatment effects on relative
weight gain, intestinal parameters, blood parameters, FISH, and
lectin hybridization from the pig studies were tested using the lmer
function of linear mixed model analysis with sow as random
variable and treatment, birth weight and sex as fixed variables.
In case of significance, pairwise analysis using the glht function was
employed to compare effects of the different treatments. Normal
distribution of all measured parameters was tested by plotting the
model residuals and by the qq-plot using the qqnorm function. All
values given in the report are adjusted means and standard error of
mean. Data are considered significant for P< 0.05.
RESULTS
In Vitro Adhesion
Genotyping of PSIc1 cells showed homozygosity (M307G/G)
for the F18 susceptible genotype of FUT1 (data not shown). Both E
coli F18 and ATCC 25922 adhered to the PSIc1 cells, which was
confirmed on culture slides by fluorescence microscopy for E coli
F18 (Fig. 1A). High doses of 20-FL (5 g/L) effectively inhibited E
coli F18 adhesion (P< 0.001; Fig. 1B), whereas inhibition of E coli
F18 adhesion was less effective but significant when lactose and to a
lesser extend maltose (not shown) was added (P< 0.001 and 0.05,
respectively). Adhesion of E coli ATCC 25922 was not affected by
20-FL or any of the control sugars (Fig. 1B).
Experiment 1: 20-FL Tolerance Study
One control pig and 1 FL-5 pig were euthanized before
completion of the protocol due to respiratory problems or apparent
sepsis. Fecal scores from these 2 pigs were included in the final
calculations. Although 3 FL-10 pigs (43%), 1 FL-5 (13%) and 2
FL-2 pigs (29%) had lost weight at euthanasia relative to their birth
weight, there was generally a slight increase in weight during the
experiment, with no difference between groups at any time point
(P¼ 0.3–0.7; Supplemental Fig. 1A, http://links.lww.com/MPG/
A704). Fecal consistency was noted from day 2 where feces first
appeared and thus resulted in 6 observations in total per pig. Pigs
from all treatment groups developed diarrhea (score 3–5) at some
point; 3 controls (38%), 3 FL-2 pigs (43%), 4 FL-5 (50%) and 2 FL-
10 pigs (29%), and mean fecal scores generally increased during the
5-day period with no difference between groups (P¼ 0.3–0.8;
Supplemental Fig. 1B, http://links.lww.com/MPG/A704). Intestinal
permeability, expressed as the lactulose/mannitol ratio, did not
differ among groups (0.02–0.12 across groups). There were no
group differences in dry weight mucosal proportions in the prox-
imal small intestine or distal small intestine (75 2% and 73 2%,
respectively).
The rectal temperature increased from 36.2 0.08C after
delivery to 39.1 0.18C on the following day in which it remained
stable until euthanasia. There was no difference between treatment
groups and all pigs remained within the normal range during the
experiment. Blood gas values showed no differences among groups,
except that FL-2 pigs had lower hematocrit values than FL-10 pigs
(22.6 1.0% vs 26.5 0.9%, P< 0.05). Across all groups, mean
hematocrit decreased from 35.2 0.6% at birth to 25.1 0.8% at
euthanasia (P< 0.05). At birth, mean pO2 and pCO2 was higher than
pO2 at euthanasia (119.5 17.3 vs 52.3 5.6 mmHg and 52.5 1.5
vs 47.6 1.8 mmHg, respectively, P< 0.05), whereas there was no
overall difference in pH (pH 7.47 0.01 vs 7.41 0.03 at birth and
euthanasia, respectively, P¼ 0.13). Blood glucose concentration
increased from birth to euthanasia (2.6 0.2 vs 5.2 0.4 mmol/L,
respectively, P< 0.05).
Experiment 2: E coli F18 Dose-Response
The incidence of diarrhea increased with time after inocu-
lation (P< 0.01), and was dose dependent with more diarrhea in
HIGH versus CON (P< 0.05), and a tendency to more diarrhea in
MED versus CON and HIGH versus LOW pigs (both P< 0.07;
Fig. 2). Body weight gain was lower in the HIGH group compared
with CON (P< 0.01), but hydration score (1.06 0.01), mucosal
proportion (77.8 3.9%), and intestinal permeability
(0.017 0.004) did not differ among groups. The abundance of
E coli in the proximal (1.1 0.04) and distal small intestine
(1.8 0.15) as measured by FISH analyses did not differ
between groups.
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FIGURE 1. Microscopic visualization of Escherichia coli F18 adhesion to PSI cells (A) where bacteria are stained with a red fluorescence dye. Mean
relative adhesion of E coli F18 and control E coli ATCC 25922 to PSI cells in vitro after addition of 2’-FL and lactose (1 and 5 g/L, B). Different
superscript letters indicate significant differences (P<0.05).
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Experiment 3: 20-FL-F18 Pig Infection Study
Because there was no difference in tolerability between the
different 20-FL doses in experiment 1, a dose of 10 g/L 20-FL was used
in the E coli F18 infection study to increase the E coli F18
antiadhesive potential of the intervention. Also the high E coli
F18 dose was chosen to ensure consistent diarrhea development
(experiment 2). All 9 F18-pigs, 6 out of 8 2FL-F18 pigs and 2 of
8 control pigs were euthanized before completion of the protocol
because of extensive diarrhea and poor clinical condition (Fig. 3A).
Nevertheless, there was no difference in the mean age at euthanasia
among the treatment groups (154 9, 141 9, and 132 8 hours for
control, 2FL-F18, and F18 pigs, respectively, P¼ 0.20). At eutha-
nasia, control and 2FL-F18 pigs tended to show less relative weight
loss than F18 pigs (P¼ 0.08; Fig. 3B). All pigs developed diarrhea
during the experiment, but overall both F18 and 2FL-F18 pigs had
more severe diarrhea, and earlier onset of diarrhea, than controls
(mean score 2.0 for F18 and 2FL-F18 pigs vs 1.2 in control pigs,
P< 0.01; Supplemental Fig. 2, http://links.lww.com/MPG/A705).
The rectal temperature increased from 36.0 0.08C after
delivery to 38.5 0.18C the following day, where it remained stable
until euthanasia. There was no difference between treatment groups
and all pigs remained within the normal range with no evidence of
fever (sepsis). Because of poor clinical status at euthanasia, blood
gasses were not obtained from 6 F18 and 6 2FL-F18 pigs and 2
controls. Plasma glucose concentrations were elevated in F18 pigs,
compared with 2FL-F18 and controls (13.5 1.4 vs 6.7 1.3 and
5.1 1.3 mmol/L, respectively, P< 0.01). Also, hematocrit was
increased in F18 pigs, compared with 2FL-F18 pigs and controls
(41.0 2.8% vs 23.2 2.2% and 28.5 1.2%, respectively,
P< 0.01). Blood pH was lowest for F18 pigs (7.17 0.11 vs
7.40 0.09 and 7.27 0.06 for F18, 2FL-F18, and controls,
respectively), but the differences were not significant (P¼ 0.34
and 0.73, respectively).
As a result of severe dehydration, urine was only obtained
from a few pigs, and lactulose and mannitol were therefore not
analyzed for permeability measures. By histological evaluation,
mucosal damage in terms of destructed villi with total or partly
sloughing of enterocytes was observed in 25%, 14%, and 44% of
controls, 2FL-F18, and F18 pigs, respectively (P¼ 0.32). F18 pigs
had shorter villi than 2FL-F18 pigs and tended to have shorter villi
than controls (P< 0.05 and P¼ 0.06, respectively, Table 1). Dry
weight mucosal proportions in the proximal and distal small
intestine was not different between groups (P¼ 0.47 and 0.41,
respectively, Table 1).
The activities of 6 brush border enzymes in the proximal and
distal small intestine were not different among groups (Table 1);
however, the 2FL-F18 pigs showed the highest mean values for all
3 disaccharidases and aminopeptidase N in the proximal intestine,
relative to F18 pigs, but the differences did not reach significance
(Table 1, P¼ 0.07–0.37). Values for aminopeptidase A and N and
dipeptidyl peptidase IV were higher in the distal small intestine
than in proximal intestine (P< 0.05 for all 3 enzymes). FISH
analyses revealed low total abundance of E coli in the distal small
intestine (Fig. 4A), where 36% of the tissues were negative for
E coli. There were no differences in mean E coli abundance among
the treatment groups (Fig. 4B), and no difference in numbers of
tissues negative for E coli (22%, 57%, and 38% for F18, 2FL-F18,
and controls, respectively, P¼ 0.3–0.8) or numbers of tissues with
high abundance (score 3–4; 29%, 22%, and 50% for F18, 2FL-F18,
and controls, respectively). Furthermore there was no significant
correlation between FISH score and mean fecal scores (P¼ 0.26).
The F18 pigs had higher relative abundance of an unclassified
Enterobacteriaceae genus, compared with control pigs (red bar,
P< 0.01; Fig. 4C), whereas Enterococcus tended to be highest for
control pigs (dark blue bar, P¼ 0.058). Compared with 2FL-F18
pigs, the control pigs had higher Enterococcus levels (P< 0.05).
The 2FL-F18 pigs had an increased relative abundance of an
unclassified Lachnospiraceae genus, compared with F18 pigs
(purple bar, P< 0.05).
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Lectin hybridization revealed modest to high levels of
a-1,2-fucose in the distal intestine (Fig. 4D), with strong staining
of goblet cells, indicating endogenous production of a-1,2-fucose.
A few pigs from all 3 treatment groups only displayed positive
staining in the lumen and there were only few observations of
a-1,2-fucose associated with the cell surface. The average score
was not affected by treatment (2.0 0.7, 2.5 0.7, and 2.3 0.7 for
controls, 2FL-F18, and F18, respectively). There were no signifi-
cant correlation between the amount of a-1,2-fucose and fecal
scores but a negative correlation was observed between
a-1,2-fucose score and E coli FISH score (P< 0.01, r¼ –0.33,
data not shown).
DISCUSSION
Breastfeeding is strongly associated with a reduced risk of
infectious diarrhea, especially in developing countries (1), and the
effect may be due to numerous bioactive compounds in human
milk. A compound that may have significant effect is 20-FL, the
major HMO in human milk, which has antiadhesive effects on the
intestinal epithelium due to its structural homology with intestinal
adhesions sites for pathogenic bacteria (9,10). This has been
demonstrated for C jejuni at a dose of 10 g/L in mice and also
for human intestinal biopsies (9). Absence of 20-FL may be a
significant factor for the increased risk of diarrhea when infants
are fed cow’s milk–based formulas and 20-FL may help to prevent
pathogenic adhesion to the intestinal mucosa. In line with our
hypothesis, we confirmed epithelial antiadhesive effects in vitro
of 20-FL on the porcine pathogen, E coli F18. In our in vivo model of
highly sensitive cesarean-delivered, formula-fed newborn pigs,
high doses of 20-FL were well tolerated but regardless, 20-FL failed
to prevent diarrhea associated with E coli F18 inoculation. Some
clinical and intestinal estimates tended to be improved in the 2FL-
F18 compared with F18 group (weight loss, blood hematocrit and
pH, mucosal damage, villus height, and proximal intestine enzyme
activities) but generally the differences did not reach statistical
significance. Dietary 20-FL may have more important effects in
response to other types of enteric infections and later into postnatal
life, but the effects on E coli F18 infection in a newly colonized,
immature intestine just after birth are minimal.
First, we determined the FUT-1 gene of the PSIc1 cells to be
homozygous for E coli F18 sensitivity (M307G/G) and demonstrated
efficient E coli F18 adhesion, which was subsequently decreased
60% when 20-FL at a dose of 5 g/L was added to the cell adhesion
model. 20-FL thereby showed more efficient inhibition than lactose,
which is a common carbohydrate source in breast milk and many
infant formulas, and 20-FL was even more effective than maltose,
also found in some infant formulas. Because 20-FL specifically
inhibited adhesion of E coli F18 and not of a control E coli, our in
vitro data indicate that the antiadhesive effect of 20-FL occurred via
an F18 fimbria-dependent mechanism. Importantly, the effect was
dose dependent, with no effect of 20-FL at the low 1.0 g/L
concentration. The 20-FL concentrations applied in vitro relates
to the physiological concentrations found in human milk, but may
not be directly translated to the in situ situation, in which dilution by
gastric and intestinal secretions and the mucus layer would reduce
the level of 20-FL in contact with the epithelium, depending on the
infants health status. Preterm infants with very immature gastro-
intestinal functions and low digestibility may have reduced capacity
to secrete these fluids and in situ concentrations may come closer to
the raw milk concentrations. Considering the 5.0 g/L as a maximum
of physiological relevant concentration, and the lacking effects at
1.0 g/L, the in vitro studies may confirm the minor effects of 20-FL
in the pig studies, even though the concentrations represents
physiological levels. The dose-dependent effect implies that optim-
ization of the dosage for in vivo administration is crucial to exert
protection from E coli F18 infections. Therefore, we first tested 20-
FL in a dose-response newborn pig study comparing a low (1 g/L),
medium (5 g/L), and high (10 g/L) dose of 20-FL without E coli F18
infection. Considering a potential risk of osmotic diarrhea, the high
dose was taken from the upper range of physiological concen-
trations in human milk (up to 8 g/L) (25–27). Even using a
relatively high dose of 20-FL, diarrhea was not prevented in new-
born pigs inoculated with E coli F18. The explanation for the lack of
effect may be related to the very immature state of the intestine and
its colonization but also the dosing of 20-FL and E coli F18. The 10
g/L 20-FL used for the formula may not result in a comparable high
concentrations at the epithelial surface since dilutions due to both
endogenous mucus production and other epithelial secretions occur.
In our in vitro studies on cells devoid of these physiological
characteristics a dose of minimum 5 g/L was needed for significant
antiadhesive effects and ex vivo studies in mice and human
intestinal biopsies required a dose of 10 g/L to inhibit adhesion
of C jejuni (9). The observed diarrhea in the 2FL-F18 group may be
partly an osmotic diarrhea because HMOs are generally indigestible
(2) leading to some accumulation of HMO in the colon where they
become fermented by bacteria. Excessive fermentation increases
the osmolality of the luminal contents and thereby induce osmotic
diarrhea (28). It is therefore possible that the diarrhea observed in
the 2FL-F18 and F18 pigs was of a different type, being more
TABLE 1. Villus height, mucosal proportion, and activity of intestinal brush border enzymes in the proximal (Prox) and distal (Dist) small intestine
of control, 2FL-F18, and F18 pigs
Control 2FL-F18 F18
Prox Dist Prox Dist Prox Dist
Villus, mm 358.3 18.8 351.3 14.1 303.5 14.4
Mucosa, % 50.0 5.9 60.4 1.6 57.3 5.1 60.0 1.3 49.1 4.4 56.3 1.4
Sucrase, U/g 0.34 0.16 0.25 0.04 0.58 0.17 0.24 0.04 0.26 0.16 0.27 0.04
Maltase, U/g 2.01 0.60 2.02 0.19 3.90 0.65 1.99 0.21 2.25 0.57 1.87 0.17
Lactase, U/g 5.15 1.77 3.48 0.68 8.54 1.86 3.47 0.74 5.18 1.65 4.26 0.63
ApN, U/g 2.23 0.58 3.53 0.62 3.00 0.60 2.62 0.66 1.96 0.57 3.41 0.61
ApA, U/g 0.88 0.30 1.79 0.28 1.31 0.31 1.47 0.29 1.16 0.29 1.33 0.27
DPPIV, U/g 0.73 0.13 2.23 0.58 1.07 0.14 2.37 0.51 0.91 0.12 2.70 0.44
Values are Mean standard error of mean.
Villus height in F18 is significantly different from 2FL-F18 (P< 0.05). ApA ¼ aminopeptidase A; ApN ¼ aminopeptidase N; DPPIV ¼ dipeptidyl
peptidase IV.
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osmotic for the 2FL-F18 pigs and more infectious for the F18 group,
in the latter group leading to more mucosal disruption as shown for
infectious diarrhea induced by ETECs (29). On the contrary, the
tendencies for 10 g/L 20-FL to reduce the weight loss, blood
parameters, and mucosal lesions in F18-infected, formula-fed pig-
lets may result from direct host tissue responses via immune
modulation, or modulation of epithelial glycosylation processes,
as shown for 20-FL and other HMOs (6,24).
We based theE coli F18 dose of 7.5 1010 cfu/day on findings
from experiment 2 in which a high dose (8 109 cfu/day)
more effectively induced diarrhea than lower doses. A previous study
indicated an apparent upper tolerability limit of 2.6 1011 cfu/day
(unpublished results). In the present 20-FL intervention study,
diarrhea was more severe in both inoculated groups compared with
control pigs. FISH analysis, however, did not reveal higher intestinal
abundance of total E coli in the inoculated groups of experiments
2 and 3. Still, data from this and an earlier study (18) document
a robust and consistent pathogen-specific induction of diarrhea by
E coli F18 in newborn, cesarean-delivered pigs. Replacement of
formula with bovine colostrum did not preventE coli F18 infection in
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FIGURE 4. Representative tissue from the distal small intestine showing high abundance ofEscherichia coli (red signal) visualized by FISH (A), and
abundance ofE coli in the treatment groups in the 2’FL F18 infection study (experiment 3) (B,means and standard error ofmean). Average relative
abundance distribution of themajor genera in colon contents of control, F18, and 2FL-F18 pigs by 16S rRNA geneMiSeq-based high-throughputs
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europaeus agglutinin I [UEA-I]) specific for a-1,2-fucose (D). The sections shown indicate tissues with fucosylation scores 1 (most left), 2, 3, and 4
(most right). FISH ¼ fluorescence in situ hybridization.
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this model (unpublished observations), despite the higher contents of
oligosaccharides in colostrum versus mature milk. Both sow’s and
cow’s milk contain significantly lower amounts of fucosylated
oligosaccharides than human milk (27), and the contents of 20-FL
in sow’s milk has not yet been reported. Regardless, it appears that the
intestine of suckling pigs is not likely to be highly dependent on
soluble 20-FL from milk for natural pathogen protection. Conversely,
our in situ hybridization analyses with the a-1,2-fucose–specific
lectin, ulex europaeus agglutinin I, revealed high endogenous
secretion ofa-1,2-fucose in the pig small intestine. The physiological
effect of these may possibly override the modest additional effect of
20-FL supplemented via the formula diet. In contrast to humans, pigs
may therefore rely more on endogenous a-1,2-fucose, explaining the
lacking or modest effects of 20-FL supplementation on enteric F18
infection in this study. Although the endogenous a-1,2-fucose could
not preventE coli F18 diarrhea in our newborn pig model, there was a
negative correlation between the level of endogenous a-1,2-fucose
and the abundance ofEcoli in general and this may reflect some effect
of a-1,2-fucose on intestinal colonization.
Our in vitro studies showed that 20-FL at a concentration of 5
g/L inhibited E coli F18 adhesion to porcine intestinal epithelial
cells. The lacking correlation between the E coli FISH score and
diarrhea score may suggest that even low titers of E coli F18 can
induce diarrhea. The binding of E coli F18 to luminal H-2 epitopes
may also not be the only mechanism whereby the pathogens adhere
to the epithelium and become virulent. In weanling pigs, E coli F18
diarrhea was most prevalent in susceptible pigs being homo- or
heterozygote for the functional FUT-1 gene, but also unsusceptible
pigs developed diarrhea (14). A similar finding was reported ex vivo
(16) and indicates that pathogenesis may occur by other means than
by binding specifically to a-1,2-fucosylated receptors. Other recep-
tors than H-2 may allow E coli F18 epithelial adhesion and a more
efficient inhibition of E coli F18 adhesion and thus decreased
prevalence of diarrhea may result from supplementation with
multiple HMOs and antimicrobial milk factors.
The increased luminal abundance of an unclassified Enter-
obacteriaceae genus in the F18 pigs (compared with controls) most
likely includes the inoculated E coli F18. The abundance of
Enterobacteriaceae in the 2FL-F18 pigs was intermediate between
values in the other 2 groups, but not significantly different from
either of them, indicating that 20-FL supplementation tend to reduce
the abundance of E coli F18. The unclassified Lachnospiraceae
family was relatively more abundant in 2FL-F18 pigs, supporting
the increase of this group in responses to HMO supplementation,
including 20-FL, in newborn pigs (30). The control group showed
the highest abundance of Enterococcus, despite that these were
increased in abundance after 20-FL supplementation in preterm pigs
(31). From the above, it seems that inoculation with E coli F18 may
override any potential effect of 2-FL on Enterococcus density.
From the present in vitro and in vivo studies we conclude that
20-FL reduces E coli F18 adhesion in the intestine of newborn,
cesarean-derived, formula-fed pigs. The employed dose of 20-FL
was not sufficient to prevent diarrhea when E coli F18 was
inoculated at a dose of 7.5 1010 cfu/day. Tendencies to improve
intestinal morphology and health in the 2FL-F18 pigs suggest only a
modest beneficial effect of 20-FL. It remains to be investigated
whether an increased dosage of 20-FL, or a longer time of exposure
in a more mature intestine, more effectively prevents pathogen-
induced intestinal infections in early life of pigs and infants.
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